Stent for valve prosthesis, and valve prosthesis
By designing stents and asymmetric artificial valve leaves that are suitable for the original valve annulus, the problem that the valve prosthesis cannot dynamically adapt to the original valve annulus during the heartbeat is solved, which improves the lifespan of the valve prosthesis and the efficiency of the heart pumping blood, and reduces the risk of heart failure.
Patent Information
- Application Number
- PCT/CN2024/090262
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-26
- Filing Date
- 2024-04-28
- Publication Date
- 2025-01-02
AI Technical Summary
Existing valve prostheses cannot dynamically adapt to the movement of the native valve annulus during the heartbeat, which affects service life and ventricular remodeling.
A stent is designed with a profile adapted to the native annex, including a first leaf portion, a joint portion and a second leaf portion distributed along its circumference, and a first leaf portion and a second leaf portion The height of the part is greater than the height of the joint part, and the stiffness is correspondingly matched. The inflow end of the stent presents a high and low in the middle, and an asymmetrically designed artificial petal leaflet is used to form blood flow channels of different sizes.
Improve the fit of the valve prosthesis with the native valve annulus, so that it can dynamically adapt to the native valve annulus during the heart contraction and diastolic process, extend its service life, reduce the impact on ventricular remodeling, and reduce the dissipation of blood flow energy , improve the efficiency of heart pumping blood and reduce the risk of heart failure.
Smart Images

Figure CN2024090262_02012025_PF_FP_ABST
Abstract
Description
Stent for valve prosthesis and valve prosthesis Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a stent for a valve prosthesis and the valve prosthesis. Background Art
[0002] The heart contains four chambers: the left atrium and left ventricle on the left side, and the right atrium and right ventricle on the right side. The inflow port is formed between the atrium and ventricle, the outflow port is formed between the left ventricle and the aorta, and the outflow port is formed between the right ventricle and the pulmonary artery. Valves function as "one-way valves" at the inflow and outflow ports, ensuring the normal flow of blood within the heart chambers. When these valves fail, cardiac hemodynamics can be altered, leading to abnormal heart function, a condition known as valvular heart disease.
[0003] With socioeconomic development and an aging population, the incidence of valvular heart disease has increased significantly. Studies have shown that the incidence of valvular heart disease in the elderly over 75 years old is as high as 13.3%. Currently, traditional surgical treatment remains the preferred treatment for patients with severe valvular disease. However, for patients of advanced age, those with multi-organ disease, those with a history of open-heart surgery, and those with poor cardiac function, traditional surgery carries significant risks and high mortality rates, and some patients may not even be eligible for surgery. Transcatheter valve replacement / repair has attracted widespread attention due to its advantages, such as the lack of open-heart surgery, minimal trauma, and rapid patient recovery. However, existing valve prostheses are too rigid after implantation. During heartbeat, native tissue compresses the valve prosthesis, shortening its lifespan. Furthermore, the reaction force exerted by the valve prosthesis on the heart affects ventricular remodeling, resulting in decreased ventricular compliance and leading to heart failure. Furthermore, implantation of existing valve prostheses alters intraventricular hemodynamics, increases ventricular energy consumption, and increases cardiac workload, leading to heart failure.
[0004] Therefore, for those skilled in the art, how to design a valve prosthesis that can dynamically adapt to the native valve annulus during cardiac contraction and relaxation is a problem that needs to be solved urgently.
[0005] It should be noted that the information disclosed in the background technology section of this application is intended to deepen the understanding of the general background technology of this application, and should not be regarded as an admission or any form of implication that the information constitutes prior art already known to those skilled in the art.
[0006] Summary of the Invention
[0007] The purpose of the present invention is to provide a stent for a valve prosthesis and a valve prosthesis to solve the problem that the existing valve prosthesis cannot dynamically adapt to the movement of the native valve ring during heart beating, thereby affecting the service life and ventricular remodeling.
[0008] To achieve the above-mentioned purpose, the present invention provides a stent for a valve prosthesis, wherein the stent has a contour adapted to the native valve ring, and the stent includes a first leaflet portion, a connection portion, and a second leaflet portion distributed along its own circumference, the connection portion being located between the first leaflet portion and the second leaflet portion, the height of the first leaflet portion and the height of the second leaflet portion both being greater than the height of the connection portion, so that the inflow end of the stent presents a shape with high ends and a low middle, and the stiffness of the first leaflet portion and the stiffness of the second leaflet portion are both less than the stiffness of the connection portion.
[0009] In one embodiment, the height of the first lobe portion is greater than the height of the second lobe portion.
[0010] In one embodiment, the distance from the first lobe portion to the center of the commissure is L1, the distance between the first lobe portion and the second lobe portion is L2, and L1 / L2≥0.5.
[0011] In one embodiment, L1 / L2≤0.8.
[0012] In one embodiment, L1 / L2=0.75.
[0013] In one embodiment, the bracket is an integrally formed structure or at least partially a split-formed structure.
[0014] In one embodiment, the inflow end of the bracket is connected to a flange, the outer diameter of the flange is larger than the outer diameter of the connection between the flange and the inflow end, and / or at least one anchor is provided on the outer surface of the bracket away from the inflow end.
[0015] In addition, based on the same inventive concept, the present invention also provides a valve prosthesis, comprising an artificial valve leaflet, a skirt, and any one of the stents for the valve prosthesis, wherein the artificial valve leaflet is fixed in the inner cavity of the stent, and the skirt covers the inner surface and / or outer surface of the stent.
[0016] In one embodiment, the artificial leaflet includes a first leaflet and a second leaflet, the size of the first leaflet is larger than the size of the second leaflet, and when the artificial leaflet is opened, the size of the blood flow channel formed by the first leaflet is larger than the size of the blood flow channel formed by the second leaflet.
[0017] In one embodiment, when the artificial leaflet is closed, the distance from the first leaflet to the center position of the commissure is greater than the distance from the second leaflet to the center position of the commissure, and the height of the first leaflet is equal to the height of the second leaflet, or, when the artificial leaflet is closed, the distance from the first leaflet to the center position of the commissure is equal to the distance from the second leaflet to the center position of the commissure, and the height of the first leaflet is greater than the height of the second leaflet.
[0018] Compared with the prior art, the stent for valve prosthesis and the valve prosthesis provided by the present invention have at least the following beneficial effects:
[0019] The stent has a contour that adapts to the native valve annulus, as well as a first leaflet portion, a commissure portion, and a second leaflet portion that adapt to the saddle-like shape of the native valve annulus. This enhances the fit of the valve prosthesis to the native valve annulus. On this basis, the first leaflet portion, the commissure portion, and the second leaflet portion are matched with different stiffnesses. This ensures that the valve prosthesis can dynamically adapt to the native valve annulus during heart contraction and relaxation, thereby increasing the life of the valve prosthesis and reducing the impact of the valve prosthesis on ventricular remodeling.
[0020] Furthermore, by limiting the distance from the first leaflet to the center of the commissure, the stent can carry an asymmetrically designed artificial leaflet, thereby forming blood flow channels of different sizes to obtain vortices similar to the original blood flow conditions of the human body, thereby reducing the dissipation of blood flow energy, improving the heart's pumping efficiency, and reducing the risk of heart failure. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Those skilled in the art will appreciate that the accompanying drawings are provided for a better understanding of the present invention and do not constitute any limitation on the scope of the present invention.
[0022] FIG1 is a schematic diagram of the overall structure of a valve prosthesis according to an embodiment of the present invention;
[0023] FIG2 a is a side view of a stent in a valve prosthesis according to an embodiment of the present invention;
[0024] FIG2 b is a schematic diagram of an end view of a stent in a valve prosthesis according to an embodiment of the present invention; FIG3 is a schematic diagram of the motion state of a native valve ring during contraction and relaxation;
[0025] Figures 4a and 4b are schematic diagrams of the structure of the first lobe portion and the second lobe portion with smaller stiffness according to an embodiment of the present invention;
[0026] Figures 5a and 5b are schematic structural diagrams of joints with greater rigidity according to an embodiment of the present invention;
[0027] FIG6 is a schematic structural diagram of a stent provided according to an embodiment of the present invention when a flange and an anchor are provided; FIG7a is a diagram showing the blood flow state when the native mitral valve is open;
[0028] Figure 7b shows the blood flow state when the mechanical valve is implanted;
[0029] FIG7 c shows the blood flow state when a symmetrically designed bioprosthesis is implanted;
[0030] FIG8 a shows the blood flow state when the valve prosthesis provided by an embodiment of the present invention is used, with arrows indicating the blood flow direction;
[0031] Figure 8b is a schematic end view of a valve prosthesis according to an embodiment of the present invention;
[0032] FIG9 shows the blood flow state when the valve prosthesis provided by an embodiment of the present invention adopts artificial valve leaflets of different heights, and the arrows indicate the blood flow direction. DETAILED DESCRIPTION
[0033] To make the content of the present invention more clear and understandable, the present invention is further described below in conjunction with the accompanying drawings. Of course, the present invention is not limited to the specific embodiments provided below, and general replacements known to those skilled in the art are also included in the scope of protection of the present invention.
[0034] The terms used in this application document are for the purpose of describing specific embodiments only and are not intended to limit this application. The singular forms of "a", "the" and "the" used in this application are also intended to include the plural forms, unless the context clearly indicates otherwise. It should be understood that similar words such as "one" or "an" do not indicate a quantity limitation, but rather indicate the presence of at least one; "plurality" indicates a quantity of two or more. Similar words such as "include" or "comprise" mean that the elements or objects appearing before "include" or "comprise" cover the elements or objects listed after "include" or "comprise" and their equivalents, and do not exclude other elements or objects. Secondly, the present invention is described in detail using schematic diagrams, but these schematic diagrams are only for the convenience of detailing examples of the present invention and should not be used as limitations of the present invention.
[0035] As used herein, "circumferential" refers to the direction around the valve prosthesis; "radial" refers to the diameter of the valve prosthesis; "axial" refers to the axial direction of the valve prosthesis, with the axial direction being perpendicular to the radial direction. The term "height" refers to the dimension along the axial direction of the stent, and "distance" refers to the dimension along the radial direction of the stent. The terms "inflow end" and "outflow end" define the position of the valve prosthesis relative to the native annulus after implantation. Based on the normal direction of blood flow, the "inflow end" is the end where blood flows into the valve prosthesis, and the "outflow end" is the end where blood flows out of the valve prosthesis. As used herein, the "inner surface" refers to the side of the valve prosthesis that is closer to the axis, and the "outer surface" refers to the side away from the axis.
[0036] The purpose of the present invention is to provide a stent for valve prosthesis and a valve prosthesis, which at least solves the problem that the existing valve prosthesis cannot dynamically adapt to the movement of the native valve during heart beating, thereby affecting the service life and ventricular remodeling.
[0037] The valve prosthesis provided by the present invention is applicable to the mitral valve or the tricuspid valve, and the following embodiments are described using the mitral valve as an example.
[0038] As shown in FIG1 , an embodiment of the present invention provides a valve prosthesis 100 , comprising a stent 110 , an artificial valve leaflet 120 , and a skirt 130 .
[0039] The artificial valve leaflet 120 is fixed in the inner cavity of the stent 110. The artificial valve leaflet 120 includes at least two leaflets. The artificial valve leaflet 120 dynamically switches between the open and closed states. When the artificial valve leaflet 120 is in the closed state, the leaflets are tightly closed or meet in a sealed abutment manner. The artificial valve leaflet 120 can be selected from biological tissues such as chemically stable tissues from the heart valves of animals (such as pigs), or pericardial tissues of animals such as cows (bovine pericardium) or sheep (sheep pericardium) or pigs (pig pericardium) or horses (equine pericardium), preferably bovine pericardial tissue. The artificial valve leaflet 120 can also be made of submucosal tissue of the small intestine. The artificial valve leaflet 120 is used to replace the native valve to perform opening and closing movements and control the direction of blood flow.
[0040] The skirt 130 can cover the inner surface of the stent 110, or cover the outer surface of the stent 110, or both the inner and outer surfaces of the stent 110 are covered with the skirt 130. The skirt 130 has a sealing function, which can prevent paravalvular leakage and better ensure that the single channel of blood flows from the inflow end of the valve prosthesis 100 to the outflow end of the valve prosthesis 100. The inflow end of the valve prosthesis 100 is usually set to adapt to the shape of the native tissue, and the skirt 130 is set circumferentially on the outer side of the inflow end where it fits with the native tissue, which can effectively prevent paravalvular leakage. The skirt 130 is made of biological materials, specifically, it can be made of knitted, woven, or braided polyester fabrics, or polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), and animal pericardial materials.
[0041] The stent 110 has a contracted state for delivery and an expanded state for deployment, and can dynamically switch between the contracted state and the expanded state. The stent 110 is a cylindrical structure that can provide several functions for the valve prosthesis 100, including: serving as the main structure of the artificial valve leaflet 120, carrying the internal valve leaflet; being able to be connected to the delivery system so as to be manipulated to achieve functions such as delivery and release. The stent body 110 can be detachably connected to the delivery system through its own connection structure such as a hook or a fixed ear. The stent 110 can be woven or cut. The stent 110 is made of materials such as nickel titanium, titanium alloy, cobalt chromium alloy, MP35n, 316 stainless steel, etc., or other biocompatible metals known to those skilled in the art, preferably nickel titanium material, and elastic or plastically deformable polymer materials, such as balloon expandable materials, can also be selected to prepare the stent 110.
[0042] As shown in Figures 2a and 2b, the stent 110 has different heights in its own circumferential direction so that the shape of the stent 110 imitates the native valve ring. In view of the fact that the native valve ring is saddle-shaped, in order to enhance the fit between the valve prosthesis 100 and the native valve ring, the stent 110 is set to a three-dimensional D-shape to imitate the shape of the native valve ring to the greatest extent. To this end, the stent 110 includes a first leaflet portion 111, a commissure 112, and a second leaflet portion 113 distributed along its own circumference. The commissure 112 is located between the first leaflet portion 111 and the second leaflet portion 113. The commissure 112 corresponds to the position where two adjacent leaflets are joined.
[0043] In one aspect, as shown in FIG2a , the height of the first leaflet portion 111 is H1, the height of the commissure portion 112 is H2, and the height of the second leaflet portion 113 is H3. The relationship among H1, H2, and H3 is H1 ≥ H3 > H2, so that the stent 110 presents a shape with high ends and low middle. On the other hand, the first leaflet portion 111, the commissure portion 112, and the second leaflet portion 113 form a profile adapted to the original valve ring in the circumferential direction of the stent 110, i.e., a D-shaped profile, which is substantially consistent with the outer contour of the native valve ring. Specifically, as shown in FIG2b , viewed along the axial direction, the overall circumferential profile of the stent 110 presents a D-shape.
[0044] Furthermore, to account for the dynamic changes of the native annulus after implantation, the stiffness of the commissure 112 is required to be greater than that of the first leaflet 111 and the second leaflet 113, so that during cardiac contraction and relaxation, the dynamic changes of the commissure 112 are smaller than those of the first leaflet 111 and the second leaflet 113. This enhances the fit of the valve prosthesis 100 to the native annulus, ensuring that the valve prosthesis 100 can dynamically adapt to the native annulus during cardiac contraction and relaxation, reducing the interaction forces between the native tissue and the valve prosthesis 100, thereby extending the service life of the valve prosthesis 100 and reducing its impact on ventricular remodeling.
[0045] Figure 3 can also be used to understand the dynamic changes of the native valve annulus. Figure 3 illustrates the motion state of the native mitral valve annulus during contraction and relaxation, where A represents the anterior leaflet, P represents the posterior leaflet, and CC represents the leaflet commissure of the native mitral valve annulus. As shown in Figure 3, when the native valve moves from relaxation to contraction, the native valve annulus moves from the left atrium to the left ventricle, and the movement amplitude of the anterior leaflet A and the posterior leaflet P is greater than the movement amplitude of the leaflet commissure CC of the native mitral valve annulus. Moreover, the anterior leaflet A and the posterior leaflet P contract toward each other, which is beneficial for the closure of the native valve and reduces regurgitation. However, in the prior art, the structure of the valve prosthesis fails to match the native valve annulus well, nor does it take into account the dynamic motion process of the native valve annulus. When the valve prosthesis 100 is implanted in the body, the compression of the artificial valve leaflets by the native tissue during the contraction and relaxation of the heart can easily lead to premature failure of the artificial valve leaflets. At the same time, the reaction force of the artificial valve leaflets on the heart can also affect ventricular remodeling, causing poor ventricular compliance and leading to heart failure. However, the valve prosthesis 100 provided by the embodiment of the present invention can better overcome the defect that the existing valve prosthesis cannot dynamically adapt to the native valve annulus.
[0046] Preferably, H1>H3>H2, which can better match the native valve ring and better adapt to the movement of the native valve, resulting in better effects.
[0047] It should be noted that there are multiple ways to make the bracket 110 have different stiffness in the circumferential direction, and at least one of them can be selected for implementation. In practice, the bracket 110 can be ensured to have different stiffness in the circumferential direction through material and / or structure. The following is an exemplary description.
[0048] In one exemplary embodiment, at least one of the first leaflet portion 111 and the second leaflet portion 113 utilizes the first structural unit 110a shown in FIG4a to provide low axial stiffness. The first structural unit 110a generally utilizes a quadrilateral mesh, including a diamond-shaped mesh, for better deformation. A plurality of first structural units 110a are provided, and the plurality of first structural units 110a are sequentially arranged along the circumference of the stent 110.
[0049] In another exemplary embodiment, at least one of the first leaflet portion 111 and the second leaflet portion 113 utilizes a helical structure 110b as shown in FIG4b , which can also provide less axial stiffness. Helical structure 110b is formed by spirally winding a primary structure and is scalable. Multiple helical structures 110b are sequentially arranged along the circumference of stent 110.
[0050] In one exemplary embodiment, the joint 112 adopts a grid structure 110c as shown in FIG5a, which can provide greater rigidity in the axial direction. A single grid structure 110c is generally provided, but the number of grid structures 110c is not limited to more than one. The grid structure 110c is a lattice structure composed of a series of strip materials intersecting vertically and horizontally.
[0051] In another exemplary embodiment, the joint portion 112 uses the second structural unit 110d shown in FIG5b. Although the second structural unit 110d uses diamond meshes, a structural reinforcement member is provided axially through all the diamond meshes to enhance rigidity. There is at least one second structural unit 110d.
[0052] However, it should be understood that the stiffness of each part of the bracket can be adjusted by changing the distribution density and size of the mesh, or by adopting other methods that can be recognized by technical personnel in this field, such as selecting materials with a small elastic modulus, etc. This application does not limit this.
[0053] The stent 110 may be manufactured as an integral part, or the first lobe portion 111 , the second lobe portion 113 and the connection portion 112 may be manufactured separately and then assembled together. Alternatively, the stent 110 may be partially a split-molded structure.
[0054] Furthermore, in view of the problem that the existing valve prosthesis easily changes the intraventricular hemodynamics after implantation, the present invention also proposes an improved solution. For ease of understanding, the intraventricular blood flow state is first described.
[0055] As shown in Figure 7a, for the native mitral valve, since the native mitral valve is a dynamic saddle-shaped valve ring and the two leaflets are asymmetrically designed, with the anterior leaflet larger than the posterior leaflet, when the mitral valve opens, it is conducive to the formation of a flow vortex A1 toward the aortic valve. The formation of vortex A1 can maintain the kinetic energy of the blood flow, and during the ventricular contraction, it is ejected from the heart, reducing the dissipation of blood kinetic energy.
[0056] As shown in Figure 7b, if a bileaflet mechanical valve is used for replacement, when the bileaflet mechanical valve opens, it will have three openings. The blood flow velocity near the opening of the aortic valve is faster, forming a vortex A2 toward the mechanical valve, which is exactly opposite to the direction of the vortex A1 formed by the native mitral valve. This changes the intraventricular hemodynamics, increases the consumption of blood kinetic energy, increases the heart load, and increases the risk of heart failure.
[0057] As shown in Figure 7c, if a bioprosthetic valve is used for replacement, most bioprosthetic valves have a symmetrical structure. When the bioprosthetic valve opens, blood flows into the left ventricle (LV) and forms two vortices A3 and A4 together with the surrounding blood with a lower blood flow velocity. The direction of one vortex A4 is exactly opposite to the direction of the vortex A1 formed by the native mitral valve, which also disperses the blood kinetic energy, increases kinetic energy consumption, increases cardiac load, and increases the risk of heart failure.
[0058] In response to the above problems, as shown in Figure 2b, the distance L1 from the first leaflet portion 111 to the center position of the commissure 112 is defined so that the stent 110 can carry the asymmetric artificial leaflet 120, thereby forming blood flow channels of different sizes. Specifically, the distance from the first leaflet portion 111 to the center position of the commissure 112 is L1, and the distance between the first leaflet portion 111 and the second leaflet portion 113 is L2, and L1 / L2 ≥ 0.5. More preferably, L1 / L2 is 0.5 to 0.8, such as the ratio of L1 to L2 is 0.5, 0.6, 0.75 or 0.8. Further preferably, L1 / L2 = 0.75, which is closer to the anatomical structure of the native valve. The position of the commissure 112 changes with the change of the ratio of L1 and L2.
[0059] Accordingly, as shown in Figures 8a to 8b and Figure 9, in a preferred embodiment of the present invention, the artificial valve leaflet 120 has an asymmetric structure. After being fixedly connected to the stent 110, blood flow channels of different sizes can be formed, thereby obtaining vortices similar to the original blood flow conditions of the human body, reducing blood flow energy dissipation, improving the heart's pumping efficiency, and reducing the risk of heart failure.
[0060] It should be understood that each leaflet in the artificial leaflet 120 includes a leaflet connection portion, a leaflet fixing portion and a leaflet free portion. One end of the leaflet free portion is connected to one end of the leaflet fixing portion through the leaflet connection portion, and the other end of the leaflet free portion is connected to the other end of the leaflet fixing portion through another leaflet connection portion. The leaflet fixing portion is basically arc-shaped or quasi-arc-shaped. Multiple leaflets are always in contact with each other at the leaflet connection portion. The leaflet free portion is an arc that bulges away from the leaflet fixing portion, or an arc that bulges toward the leaflet fixing portion, or is straight. The leaflet connection portion and the leaflet fixing portion of the leaflet both need to be fixedly connected to the stent 110. When the artificial leaflet 120 is closed, the leaflet free portions of each leaflet are tightened or converged in a sealed abutment manner. When the artificial leaflet 120 is opened, the leaflet free portions of each leaflet are opened away from each other to allow blood to pass through.
[0061] As shown in Figure 8a, the artificial valve leaflet 120 is fixedly connected to the first leaflet portion 111, the commissure portion 112, and the second leaflet portion 113 of the stent 110. The connection between the artificial valve leaflet 120 and the stent 110 can be achieved by suturing, bonding, or integral molding.
[0062] As shown in FIG8b , the artificial valve leaflet 120 uses an asymmetric leaflet, including a first leaflet 121 and a second leaflet 122. The size of the first leaflet 121 is larger than that of the second leaflet 122. It can also be understood that when the leaflets are flattened, the planar size of the first leaflet 121 is larger than the planar size of the second leaflet 122. With this arrangement, when the artificial valve leaflet 120 is opened, the size of the blood flow channel formed by the first leaflet 121 is larger than the size of the blood flow channel formed by the second leaflet 122, which can cause the blood flow to form a vortex (A1) toward the aortic valve, similar to the natural blood flow in the human body, which can reduce the dissipation of blood kinetic energy and improve the heart's pumping efficiency.
[0063] It should be understood that in the mitral valve application scenario, the artificial valve leaflet 120 includes a first leaflet 121 and a second leaflet 122, while in the tricuspid valve application scenario, the artificial valve leaflet 120 includes a first leaflet 121 and two second leaflets 122. The first leaflet 121 is connected to the first leaflet portion 111 and the commissure 112, and the second leaflet 122 is connected to the second leaflet portion 113 and the commissure 112.
[0064] As shown in Figures 8a and 8b, similar to stent 110, the distance between first leaflet 121 and the center of commissure 112 is L1, and the distance between first leaflet 121 and second leaflet 122 is L2. L1 / L2 is greater than 1 / 2. In this case, the distance between second leaflet 122 and the center of commissure 112 is less than L1. Moreover, when artificial leaflet 120 is closed, the first leaflet 121 and the second leaflet 122 are at equal heights in the axial direction of stent 110. In this way, an asymmetric design of artificial leaflet 120 can be achieved, so that when artificial leaflet 120 is opened, the blood flow channel of first leaflet 121 is larger than that of second leaflet 122.
[0065] As shown in FIG9 , in another exemplary embodiment, L1 / L2=1 / 2. In this case, the distance from the second leaflet 122 to the center of the commissure 112 is also L1. The difference is that when the artificial leaflet 120 is closed, the heights of the first leaflet 121 and the second leaflet 122 in the axial direction of the stent 110 are not equal. The height of the first leaflet 121 is h1, and the height of the second leaflet 122 is h2. h1>h2, and the height difference between the two is h. In this way, an asymmetric design of the artificial leaflet 120 can also be achieved, so that when the artificial leaflet 120 is opened, the blood flow channel of the first leaflet 121 is larger than that of the second leaflet 122, which is equivalent to the blood flow channel of the first leaflet 121 having an additional height difference h than that of the second leaflet 122.
[0066] 6 , in one exemplary embodiment, the inflow end of the stent 110 is connected to a flange 114. The flange 114 is used to adhere closely to native tissue when the valve prosthesis 100 is deployed, further preventing paravalvular leakage and improving anchoring performance. The outer diameter of the flange 114 is larger than the outer diameter of the connection between the flange 114 and the inflow end of the stent 110, so that the outer surface of the flange 114 can adhere closely to the native valve annulus and leaflets. The edge of the flange 114 can adhere closely to the inner wall of the left atrium, acting as a limiter and seal to prevent the valve prosthesis 100 from sliding toward the left ventricle. The outer diameter at the edge of the flange 114 is the maximum diameter of the flange 114, and the outer diameter at the connection between the flange 114 and the stent 110 is the minimum diameter of the flange 114. The flange 114 is relatively soft and easily compressed and deformed.
[0067] Continuing with FIG6 , in one exemplary embodiment, at least one anchor 115 is disposed on the outer surface of the stent 110 distal from the inflow end. Anchor 115 can grasp native structures (e.g., native leaflets) during deployment of the valve prosthesis 100, facilitating the fixation of the valve and native tissue. The specific location of anchor 115 on stent 110 is not limited, nor is the number of anchors 115. Anchor 115 can have a variety of configurations, and at least one structure can be selected to implement the configuration, such as a barb, a hook, an anchor, a slender member, or the like.
[0068] The delivery method of the valve prosthesis 100 of the embodiment of the present invention is not limited. Common delivery methods include delivery via the femoral artery, transapical route, transjugular vein route, etc.
[0069] In summary, compared with the prior art, the valve prosthesis and stent provided by the present invention have at least the following advantages:
[0070] (1) A three-dimensional D-shaped stent is used to adapt the structure of the stent to the structure of the native valve annulus. Different parts of the stent are matched with different stiffnesses to ensure that the valve prosthesis can dynamically adapt to the native valve annulus during cardiac contraction and relaxation, thereby increasing the life of the valve prosthesis and reducing the impact of the valve prosthesis on ventricular remodeling.
[0071] (2) Asymmetric artificial valve leaflets are used to form blood flow channels of different sizes, thereby obtaining vortices similar to the original blood flow conditions of the human body, thereby reducing the dissipation of blood flow energy, improving the heart's pumping efficiency, and reducing the risk of heart failure.
[0072] It should be noted that those skilled in the art may make several improvements and additions without departing from the disclosure of the present invention, and such improvements and additions shall also be considered within the scope of protection of the present invention. Any equivalent changes, modifications, and evolutions made by those skilled in the art using the technical content disclosed above without departing from the spirit and scope of the present invention shall be considered equivalent embodiments of the present invention; at the same time, any equivalent changes, modifications, and evolutions made to the above embodiments based on the essential technology of the present invention shall still fall within the scope of the technical solution of the present invention.
Claims
1. A stent for a valve prosthesis, characterized in that: The stent has a contour adapted to the native valve ring, and the stent includes a first leaflet portion, a connection portion, and a second leaflet portion distributed along its own circumference, the connection portion is located between the first leaflet portion and the second leaflet portion, and along the axial direction of the stent, the height of the first leaflet portion and the height of the second leaflet portion are both greater than the height of the connection portion, so that the inflow end of the stent presents a shape with high ends and a low middle, and the stiffness of the first leaflet portion and the stiffness of the second leaflet portion are both less than the stiffness of the connection portion.
2. The stent for valve prosthesis according to claim 1, characterized in that: Along the axial direction of the stent, the height of the first leaflet portion is greater than the height of the second leaflet portion.
3. The stent for valve prosthesis according to claim 1, characterized in that: Along a radial direction perpendicular to the axial direction of the stent, a distance from the first leaflet portion to a center position of the commissure portion is L1, a distance between the first leaflet portion and the second leaflet portion is L2, and L1 / L2≥0.
5.
4. The stent for valve prosthesis according to claim 3, characterized in that: L1 / L2≤0.
8.
5. The stent for valve prosthesis according to claim 4, characterized in that: L1 / L2=0.
75.
6. The stent for valve prosthesis according to claim 1, characterized in that: The bracket is an integrally formed structure or at least partially a split-formed structure.
7. The stent for valve prosthesis according to claim 1, characterized in that: The inflow end of the bracket is connected to a flange, the outer diameter of the flange is larger than the outer diameter of the connection between the flange and the inflow end, and / or at least one anchor is arranged on the outer surface of the bracket away from the inflow end.
8. The stent for valve prosthesis according to claim 1, characterized in that: The first leaflet portion, the commissure portion and the second leaflet portion form a D-shaped contour in the circumferential direction of the stent.
9. The stent for valve prosthesis according to claim 1, characterized in that: At least one of the first lobe portion and the second lobe portion adopts a first structural unit, and the first structural unit adopts a quadrilateral mesh.
10. The stent for valve prosthesis according to claim 9, characterized in that: The first structural unit is provided in plurality, and the plurality of first structural units are sequentially arranged along the circumference of the bracket.
11. The stent for valve prosthesis according to claim 1, characterized in that: At least one of the first lobe portion and the second lobe portion adopts a spiral structure, and the spiral structure is formed by spirally winding a primary structure and is retractable.
12. The stent for valve prosthesis according to claim 1, characterized in that: The joint part adopts a grid structure, and the grid structure is a grid structure composed of intersecting strip materials; or The connecting portion adopts a second structural unit, which includes a diamond mesh and a structural reinforcement member that is axially arranged and passes through the diamond mesh.
13. A valve prosthesis, characterized in that: It comprises an artificial valve leaflet, a skirt and a stent for a valve prosthesis as described in any one of claims 1 to 12, wherein the artificial valve leaflet is fixed in the inner cavity of the stent, and the skirt covers the inner surface and / or outer surface of the stent.
14. The valve prosthesis according to claim 13, characterized in that: The artificial valve leaflet includes a first leaflet and a second leaflet, the size of the first leaflet is larger than the size of the second leaflet, and when the artificial valve leaflet is opened, the size of the blood flow channel formed by the first leaflet is larger than the size of the blood flow channel formed by the second leaflet.
15. The valve prosthesis according to claim 14, characterized in that: When the artificial leaflet is closed, the distance from the first leaflet to the center of the connection is greater than the distance from the second leaflet to the center of the connection, and the height of the first leaflet is equal to the height of the second leaflet; or, when the artificial leaflet is closed, the distance from the first leaflet to the center of the connection is equal to the distance from the second leaflet to the center of the connection, and the height of the first leaflet is greater than the height of the second leaflet.
Citation Information
Patent Citations
Atrioventricular valve stent for puncture placement and conveying system thereof
CN106943207A
Prosthetic mitral valve comprising annular-ventricular coupling mechanism
CN109475408A
Cardiac valve and valve conveying device
CN112022441A
Heart valve prosthesis
CN113855326A
Bracket for repairing mitral valve
CN114831778A
